The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

Popular weight loss drugs may come with some unexpected downsides, according to new research. And a separate study finds grandparents could be a powerful force in helping teenagers through a growing mental health crisis.

Florida-native grocer Publix announced on Tuesday that it is now offering a new brochure to help customers with their weight-loss journeys.

U.S. health officials have approved a new weight-loss pill from Eli Lilly.

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.

The biggest new restaurant trend is small.

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss drugs.

U.S. regulators have approved a pill version of the weight-loss drug Wegovy.

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid or state employee insurance programs are scrambling to lessen the budgetary squeeze from fast-rising costs.

When starting a weight loss journey, one of the first things you might think about is how to build a balanced, nutritious diet to set yourself up for success.

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials decided to indefinitely pause covering their use for weight loss patients because of the cost.

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.